Back to results
US 2002/0058037 A1Published application
Use of anti-gp-39 antibodies for treatment and/or reversal of lupus and lupus associated kidney disease
AssigneeTrustees of Dartmouth College
InventorsRandolph J. Noelle, Christopher M. Burns
Life of this patent
Estimating the term…
Abstract
A method of treating lupus using anti-gp39 antibodies or fragments is provided. Such treatment has been shown to reverse disease, and in particular lupus-associated kidney disease, the major killer of lupus subjects.
Claims10
A method of treating lupus in a subject in need of such treatment which comprises administering a therapeutically effective amount of an anti-gp39 antibody or a fragment thereof that specifically binds gp39.
Dependencies are inferred from the claim text.